Maurer Mathew S, Kronzon Itzhak, Burkhoff Daniel
Division of Geriatric Medicine and Aging, Department of Medicine, Columbia University Medical Center, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Prog Cardiovasc Dis. 2006 Nov-Dec;49(3):182-95. doi: 10.1016/j.pcad.2006.08.007.
The syndrome of heart failure in the setting of normal ejection fraction (HFNEF) is manifest in a clinically heterogeneous group of patients with multiple and varied comorbid conditions. In this report, we review available data derived from pressure-volume (PV) analyses in patients with and in animal models of HFNEF. Pressure-volume analysis of ventricular function is challenging in the clinical setting but provides unique insights into the systolic, diastolic, and overall pumping characteristics of the heart. Results of such analyses have thus far been limited to small cohorts of patients but suggest that different cohorts of patients with HFNEF having PV relations that imply different pathophysiologic mechanisms exist. This emphasizes the need to take a view of this syndrome, which extends beyond diastolic dysfunction, particularly when it comes to proposing and investigating therapeutic targets. We therefore propose that progress can be made in advancing therapeutics for HFNEF if it is appreciated that different underlying pathophysiologic mechanisms may be important in different cohorts and if attention expands beyond diastolic dysfunction as the sole target. Similar to the success that was achieved in advancing therapeutics for systolic heart failure when attention shifted away from the heart to the neurohormonal and renal axes, our interpretation of data in human beings and in animal models suggests that addressing similar targets (perhaps not in exactly the same manner) may prove to be fruitful, at least for some patients with HFNEF as well.
射血分数正常的心力衰竭综合征(HFNEF)在患有多种合并症的临床异质性患者群体中表现出来。在本报告中,我们回顾了来自HFNEF患者和动物模型压力-容积(PV)分析的现有数据。心室功能的压力-容积分析在临床环境中具有挑战性,但能提供对心脏收缩、舒张和整体泵血特性的独特见解。迄今为止,此类分析的结果仅限于小部分患者队列,但表明不同的HFNEF患者队列存在不同的PV关系,这意味着存在不同的病理生理机制。这强调了需要对该综合征有更全面的认识,这种认识应超越舒张功能障碍,特别是在提出和研究治疗靶点时。因此,我们认为,如果认识到不同的潜在病理生理机制在不同队列中可能很重要,并且如果关注范围超越舒张功能障碍这一唯一靶点,那么在推进HFNEF治疗方面就可以取得进展。与将注意力从心脏转向神经激素和肾脏轴时在收缩性心力衰竭治疗方面取得的成功类似,我们对人类和动物模型数据的解读表明,针对类似靶点(或许方式不完全相同)可能也会有成效,至少对一些HFNEF患者也是如此。